Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Follicular Non-Hodgkin's Lymphoma Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05152459
What this trial is testing

Tazemetostat in Combination With Umbralisib and Ublituximab for the Treatment Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Recurrent Follicular LymphomaRefractory Follicular Lymphoma
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT00006348
What this trial is testing

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Alliance for Clinical Trials in Oncology 100
Not applicableStudy completedNCT00293384
What this trial is testing

Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Barbara Ann Karmanos Cancer Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT04680052
What this trial is testing

Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Incyte Corporation 654
Testing effectiveness (Phase 2)Ended earlyNCT04358458
What this trial is testing

First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas

Who this might be right for
Diffuse Large B-cell LymphomaFollicular LymphomaMarginal Zone Lymphoma+5 more
Genmab 46
Testing effectiveness (Phase 2)Study completedNCT00005626
What this trial is testing

Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)

Who this might be right for
LeukemiaLymphoma
H. Lee Moffitt Cancer Center and Research Institute 10
Testing effectiveness (Phase 2)Study completedNCT00004171
What this trial is testing

Peripheral Stem Cell Transplantation Following Radiation Therapy in Treating Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT00521014
What this trial is testing

GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 14
Testing effectiveness (Phase 2)Study completedNCT00003408
What this trial is testing

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Cancer Treatment Centers of America 40
Testing effectiveness (Phase 2)Study completedNCT03997968
What this trial is testing

CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors

Who this might be right for
MalignancyNon-hodgkin LymphomaMultiple Myeloma+12 more
Cyteir Therapeutics, Inc. 169
Not applicableEnded earlyNCT00255684
What this trial is testing

Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
University of Rochester 16
Testing effectiveness (Phase 2)Ended earlyNCT00719849
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Fred Hutchinson Cancer Center 13
Very early researchUnknownNCT04767308
What this trial is testing

Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies

Who this might be right for
CD5+ Relapsed/Refractory Hematopoietic MalignanciesChronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)+3 more
Huazhong University of Science and Technology 18
Testing effectiveness (Phase 2)Study completedNCT00003143
What this trial is testing

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 20
Early research (Phase 1)Active Not RecruitingNCT01815749
What this trial is testing

Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+21 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT00045006
What this trial is testing

Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004084
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 21
Early research (Phase 1)Ended earlyNCT01609816
What this trial is testing

Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaMultipleMycosis Fungoides+2 more
Barbara Ann Karmanos Cancer Institute 8
Early research (Phase 1)Not Yet RecruitingNCT07024147
What this trial is testing

JWCAR239 in Patients With B Cell Non-Hodgkin Lymphoma

Who this might be right for
B-Cell Non-Hodgkin LymphomaLarge B Cell Diffuse LymphomaFollicular Lymphoma+2 more
Peking University Cancer Hospital & Institute 20
Next Page
30